Robert Kraft Net Worth

The estimated Net Worth of Robert O. Kraft is at least $1.58 Million dollars as of 22 August 2024. Mr. Kraft owns over 8,127 units of Medpace Inc stock worth over $1,436,644 and over the last 9 years he sold MEDP stock worth over $0. In addition, he makes $144,994 as Independent Director at Medpace Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. Kraft MEDP stock SEC Form 4 insiders trading

Robert has made over 9 trades of the Medpace Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he exercised 8,127 units of MEDP stock worth $346,373 on 22 August 2024.

The largest trade he's ever made was exercising 13,782 units of Medpace Inc stock on 14 August 2023 worth over $364,396. On average, Robert trades about 1,105 units every 23 days since 2015. As of 22 August 2024 he still owns at least 4,294 units of Medpace Inc stock.

You can see the complete history of Mr. Kraft stock trades at the bottom of the page.

Robert Kraft biography

Robert O. Kraft serves as Independent Director of the Company since July 1, 2016. Mr. Kraft has served as the Chief Financial Officer and Treasurer of The Hillman Companies, Inc. and The Hillman Group since November 2017. Mr. Kraft served as the Executive Vice President of CVS Health Corporation and the President of Omnicare, Inc., CVS’s long-term care business, from August 2015 to September 2017. From September 2012 to August 2015, Mr. Kraft served as Senior Vice President and Chief Financial Officer of Omnicare, Inc., and from November 2010 to September 2012, he served as Senior Vice President, Finance of Omnicare, Inc. Before joining Omnicare, Inc., Mr. Kraft was an audit partner at PricewaterhouseCoopers LLP, where he worked for 18 years. Mr. Kraft received his Bachelor’s Degree in Accounting from the University of Dayton. Mr. Kraft was chosen as a director because of his significant financial and accounting experience from his background as an audit partner at PricewaterhouseCoopers LLP and his experience as an executive of a public company.

What is the salary of Robert Kraft?

As the Independent Director of Medpace Inc, the total compensation of Robert Kraft at Medpace Inc is $144,994. There are 9 executives at Medpace Inc getting paid more, with August Troendle having the highest compensation of $7,712,840.

How old is Robert Kraft?

Robert Kraft is 49, he's been the Independent Director of Medpace Inc since 2016. There are 10 older and 4 younger executives at Medpace Inc. The oldest executive at Medpace Holdings Inc is Fred Davenport, 68, who is the Lead Independent Director.

What's Robert Kraft's mailing address?

Robert's mailing address filed with the SEC is C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI, OH, 45227.

Insiders trading at Medpace Inc

Over the last 8 years, insiders at Medpace Inc have traded over $3,140,136,825 worth of Medpace Inc stock and bought 2,899,276 units worth $330,034,155 . The most active insiders traders include Limited Partnership Medpace..., August J. Troendle, and Investors, Llc Medpace. On average, Medpace Inc executives and independent directors trade stock every 9 days with the average trade being worth of $40,224,347. The most recent stock trade was executed by Robert O. Kraft on 22 August 2024, trading 8,127 units of MEDP stock currently worth $346,373.

What does Medpace Inc do?

a therapeutically focused leader in research-based drug development, medpace builds strong strategic partnerships with select sponsors to advance the most efficient and cost-effective path to drug approval. as a full service, global clinical research organization (cro), medpace sees itself as a steward of your drug, leveraging its extensive medical and regulatory expertise to deliver additional input, strategy, and efficiencies to each and every phase of the clinical trial. from custom solutions addressing the needs of small and midsize biotechnology companies to full-service offerings for global pharmaceutical companies, medpace has the breadth, depth, and flexibility to deliver a superior result, specific to your needs, on six continents.

Complete history of Mr. Kraft stock trades at Medpace Inc and CVS Health Corp

Medpace Inc executives and stock owners

Medpace Inc executives and other stock owners filed with the SEC include:

• August Troendle,
  Chairman of the Board, President, Chief Executive Officer
• Susan Burwig,
  Executive Vice President - Operations
• Jesse Geiger,
  Chief Financial Officer, Chief Operating Officer - Laboratory Operations
• Stephen Ewald,
  General Counsel, Corporate Secretary
• Dr. August James Troendle M.D.,
  Chairman & CEO
• Susan E. Burwig,
  Exec. VP of Operations
• Jesse J. Geiger BBA, CPA,
  Pres
• Stephen P. Ewald,
  Chief Compliance Officer, Gen. Counsel & Corp. Sec.
• Brian Carley,
  Independent Director
• Robert Kraft,
  Independent Director
• Fred Davenport,
  Lead Independent Director
• Cornelius McCarthy,
  Independent Director
• Ashley Keating,
  Independent Director
• Thomas King,
  Independent Director
• Brandon Ebken,
  Chief Information Officer
• John T. Wynne,
  Sr. VP of Commercial Operations & Clinical Pharmacology Unit
• Daniel O'Leary,
  Sr. VP of Medical Department
• Weimin Gai MS,
  Sr. VP of Biometrics
• Todd Meyers,
  VP of Bus. Devel. & Marketing
• Lauren Morris,
  Associate Director of Investors Relations
• Kevin M. Brady,
  CFO & Treasurer
• Penelope J Bucknell,
  VP, Human Resources
• Bruce Brown,
  Director
• Cinven Fund (No. 1) Limited...,
  
• Limited Partnership Medpace...,
  
• Dani S. Zander,
  Director
• Investors, Llc Medpace,
  10% owner
• Tom C King,
  Director
• Kevin M. Brady,
  CFO & Treasurer